ARCHIVES

NCAB Hung Up On removing $ 45 Million Limit For Core Grants

This article is from The Cancer Letter archive.

Vol. 02 No. 38 | September 17, 1976

Download PDF Visit The Full Archive

Related Articles

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

Bailes: ASCO To Strengthen State Affiliates, Begin Quality Of Care Study, Talk With FDA.

May 26, 2000

Congress Approves More Favorable Terms for Office-Administered Drugs

August 8, 1997

Funding Opportunity: Defense Department Offering $30.5 Mil In Research Grants

April 18, 2014

New Understanding of drug Resistance Exciting Revolution

September 17, 1982

Obey Strikes Again, Earmarks NCI Positions

July 2, 1976